These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35469973)

  • 1. Parents' experiences of using a hybrid closed-loop system (CamAPS FX) to care for a very young child with type 1 diabetes: Qualitative study.
    Kimbell B; Rankin D; Hart RI; Allen JM; Boughton CK; Campbell F; Fröhlich-Reiterer E; Hofer SE; Kapellen TM; Rami-Merhar B; Schierloh U; Thankamony A; Ware J; Hovorka R; Lawton J;
    Diabetes Res Clin Pract; 2022 May; 187():109877. PubMed ID: 35469973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parents' experiences of using remote monitoring technology to manage type 1 diabetes in very young children during a clinical trial: Qualitative study.
    Hart RI; Kimbell B; Rankin D; Allen JM; Boughton CK; Campbell F; de Beaufort C; Fröhlich-Reiterer E; Ware J; Hofer SE; Kapellen TM; Rami-Merhar B; Thankamony A; Hovorka R; Lawton J;
    Diabet Med; 2022 Jul; 39(7):e14828. PubMed ID: 35274356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents' Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study.
    Rankin D; Kimbell B; Allen JM; Besser REJ; Boughton CK; Campbell F; Elleri D; Fuchs J; Ghatak A; Randell T; Thankamony A; Trevelyan N; Wilinska ME; Hovorka R; Lawton J
    J Diabetes Sci Technol; 2021 Sep; 15(5):1042-1051. PubMed ID: 34261348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents.
    Hood KK; Garcia-Willingham N; Hanes S; Tanenbaum ML; Ware J; Boughton CK; Allen JM; Wilinska ME; Tauschmann M; Denvir L; Thankamony A; Campbell F; Wadwa RP; Buckingham BA; Davis N; DiMeglio LA; Mauras N; Besser REJ; Ghatak A; Weinzimer SA; Fox DS; Kanapka L; Kollman C; Sibayan J; Beck RW; Hovorka R;
    Diabetes Obes Metab; 2022 Dec; 24(12):2309-2318. PubMed ID: 35837984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parents' views about healthcare professionals having real-time remote access to their young child's diabetes data: Qualitative study.
    Kimbell B; Rankin D; Hart RI; Allen JM; Boughton CK; Campbell F; Fröhlich-Reiterer E; Hofer SE; Kapellen TM; Rami-Merhar B; Schierloh U; Thankamony A; Ware J; Hovorka R; Lawton J;
    Pediatr Diabetes; 2022 Sep; 23(6):799-808. PubMed ID: 35561092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial.
    Kimbell B; Rankin D; Ashcroft NL; Varghese L; Allen JM; Boughton CK; Campbell F; Ghatak A; Randell T; Besser REJ; Trevelyan N; Hovorka R; Lawton J
    Diabetes Technol Ther; 2020 Jun; 22(6):468-475. PubMed ID: 32048877
    [No Abstract]   [Full Text] [Related]  

  • 7. Parents' experiences of managing their child's diabetes using an insulin pump: a qualitative study.
    Rankin D; Harden J; Noyes K; Waugh N; Barnard K; Lawton J
    Diabet Med; 2015 May; 32(5):627-34. PubMed ID: 25581347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes for older adults on CamAPS FX closed loop system.
    Schneider-Utaka AK; Hanes S; Boughton CK; Hartnell S; Thabit H; Mubita WM; Draxlbauer K; Poettler T; Hayes J; Wilinska ME; Mader JK; Narendran P; Leelarathna L; Evans ML; Hovorka R; Hood KK
    Diabet Med; 2023 Sep; 40(9):e15126. PubMed ID: 37171467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescents' and their parents' experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study.
    Rankin D; Kimbell B; Hovorka R; Lawton J
    Chronic Illn; 2022 Dec; 18(4):742-756. PubMed ID: 33472409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
    Musolino G; Dovc K; Boughton CK; Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Ashcroft N; Wilinska ME; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Pediatr Diabetes; 2019 Sep; 20(6):794-799. PubMed ID: 31140654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
    Thabit H; Boughton C; Mubita W; Rubio J; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Gregory AM; Hovorka R; Rutter MK
    Diabetes Obes Metab; 2023 Mar; 25(3):889-893. PubMed ID: 36335565
    [No Abstract]   [Full Text] [Related]  

  • 12. Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and Solutions.
    Rankin D; Hart RI; Kimbell B; Barnard-Kelly K; Brackenridge A; Byrne C; Collett C; Dover AR; Hartnell S; Hunt KF; Lee TTM; Lindsay RS; McCance DR; McKelvey A; Rayman G; Reynolds RM; Scott EM; White SL; Hovorka R; Murphy HR; Lawton J
    Diabetes Technol Ther; 2023 Apr; 25(4):260-269. PubMed ID: 36662589
    [No Abstract]   [Full Text] [Related]  

  • 13. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
    Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
    Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
    Boughton CK; Hartnell S; Thabit H; Poettler T; Herzig D; Wilinska ME; Ashcroft NL; Sibayan J; Cohen N; Calhoun P; Bally L; Mader JK; Evans M; Leelarathna L; Hovorka R
    Diabetes Obes Metab; 2021 Jun; 23(6):1389-1396. PubMed ID: 33606901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid closed-loop therapy with a first-generation system increases confidence and independence in diabetes management in youth with type 1 diabetes.
    Roberts A; Fried L; Dart J; de Bock M; Fairchild J; King B; Ambler GR; Cameron F; McAuley SA; Keech AC; Jenkins A; O Neal DN; Davis EA; Jones TW; Abraham MB;
    Diabet Med; 2022 Sep; 39(9):e14907. PubMed ID: 35757899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study.
    Lawton J; Rankin D; Hartnell S; Lee T; Dover AR; Reynolds RM; Hovorka R; Murphy HR; Hart RI;
    Diabet Med; 2023 May; 40(5):e15072. PubMed ID: 36807582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid closed-loop therapy: Where are we in 2021?
    Leelarathna L; Choudhary P; Wilmot EG; Lumb A; Street T; Kar P; Ng SM
    Diabetes Obes Metab; 2021 Mar; 23(3):655-660. PubMed ID: 33269551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
    Fuchs J; Allen JM; Boughton CK; Wilinska ME; Thankamony A; de Beaufort C; Campbell F; Yong J; Froehlich-Reiterer E; Mader JK; Hofer SE; Kapellen TM; Rami-Merhar B; Tauschmann M; Hood K; Kimbell B; Lawton J; Roze S; Sibayan J; Cohen N; Hovorka R;
    BMJ Open; 2021 Feb; 11(2):e042790. PubMed ID: 33579766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
    Kariyawasam D; Morin C; Casteels K; Le Tallec C; Sfez A; Godot C; Huneker E; Garrec N; Benhamou PY; Polak M; Charpentier G; Franc S; Beltrand J
    Lancet Digit Health; 2022 Mar; 4(3):e158-e168. PubMed ID: 35216750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol.
    Lee TTM; Collett C; Man MS; Hammond M; Shepstone L; Hartnell S; Gurnell E; Byrne C; Scott EM; Lindsay RS; Morris D; Brackenridge A; Dover AR; Reynolds RM; Hunt KF; McCance DR; Barnard-Kelly K; Rankin D; Lawton J; Bocchino LE; Sibayan J; Kollman C; Wilinska ME; Hovorka R; Murphy HR;
    BMC Pregnancy Childbirth; 2022 Apr; 22(1):282. PubMed ID: 35382796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.